North Carolina may lose pharma project after passing law targeting LGBT community

Two weeks ago North Carolina governor Gov. Pat McCrory was pointing to a proposed project by New Jersey-based Braeburn Pharmaceuticals and bragging about what a great job the state has done attracting pharma companies. But Braeburn is having second thoughts about the state after the governor last week signed a bill that eliminated local protections for gay and transgender people and limits the bathroom choices they have. In a statement to WNCN in Durham, NC, Braeburn called the law "unjust. It is slated to receive up to $275,000 in incentives for the project. "Braeburn Pharmaceuticals believes in fair treatment and equality for all individuals in their communities. We oppose any legislation that discriminates against the LGBT community," the company said. More from FiercePharmaManufacturing

Suggested Articles

Pfizer will exit its Perth, Australia sterile injectables manufacturing site by 2024 as part of a global production reorganization effort.

Agios has withdrawn a European application for Tibsovo in AML after the same phase 1 data that earned it an FDA nod failed to impress the EMA.

Sanofi is reportedly considering a sale of some of its anti-inflammation drugs that could snare $234 million as the company pivots toward Dupixent.